TCF7L1 and urinary bladder cancer: Rescue experiments showed that after overexpression of TCF7L1 and knocking down HSPB6, the expression of these proteins was reversed, indicating that TCF7L1 targeting HSPB6 is involved in the pathological process of EMT in bladder cancer.